share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director DEPARLE NANCY ANN

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director DEPARLE NANCY ANN

西维斯健康 | 4:持股变动声明-董事 DEPARLE NANCY ANN
美股sec公告 ·  05/17 17:38
Moomoo AI 已提取核心信息
Nancy Ann Deparle, reported a completed acquisition of CVS Health Corp (CVS) common stock on May 16, 2024. The transaction involved the purchase of 2,314 shares at a price of $57.52 per share. Following this transaction, Deparle directly holds a total of 31,838 shares in the company. The acquisition, characterized as a grant, award, or other acquisition, reflects a positive investment move in the company by the reporting person.
Nancy Ann Deparle, reported a completed acquisition of CVS Health Corp (CVS) common stock on May 16, 2024. The transaction involved the purchase of 2,314 shares at a price of $57.52 per share. Following this transaction, Deparle directly holds a total of 31,838 shares in the company. The acquisition, characterized as a grant, award, or other acquisition, reflects a positive investment move in the company by the reporting person.
南希·安·德帕勒报告说,已于2024年5月16日完成对CVS Health Corp(CVS)普通股的收购。该交易涉及以每股57.52美元的价格购买2314股股票。在这笔交易之后,Deparle直接持有该公司总共31,838股股份。此次收购以补助金、奖励或其他收购为特征,反映了申报人对公司的积极投资举措。
南希·安·德帕勒报告说,已于2024年5月16日完成对CVS Health Corp(CVS)普通股的收购。该交易涉及以每股57.52美元的价格购买2314股股票。在这笔交易之后,Deparle直接持有该公司总共31,838股股份。此次收购以补助金、奖励或其他收购为特征,反映了申报人对公司的积极投资举措。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息